NPS's Nader on Drug Research, Growth Strategy

Feb. 25 (Bloomberg) -- Francois Nader, chief excutive officer for NPS Pharmaceuticals Inc., talks about cost strategy and product development. Nader speaks with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance." Stanley Collender, managing director for Qorvis Communications LLC, also speaks. (Source: Bloomberg)
Is Commodities Rout a Money Making Opportunity?
03:12 - Michael Haigh, global head of commodities research at Societe Generale, discusses the factors dragging down commodities prices, why he sees a buying opportunity created by the drop and which commodities might be the best long-term bet. He speaks on "Market Makers." (Source: Bloomberg)
  • Three Things That Are Moving Today's Markets
  • Shanghai Market a Government Operation: Donald Strasheim
  • Parsing the Fed: Surveillance (Full Show 07/30)